Dr. Supratik Bhattacharyya - AMRI Hospitals










Home / Find a Doctor / DR SUPRATIK BHATTACHARYYA
DR SUPRATIK BHATTACHARYYA
DR SUPRATIK BHATTACHARYYA
Qualifcation MD, MRCP (UK), FACP (USA), FRCP (EDIN)
Specialities Diabetes and Endocrinology
Specialities

Diabetes and Endocrinology

Area of Interests

  • Adult and Paediatric Endocrine Disorders
  • PCOS
  • Diabetes and Metabolic disorders
  • Thyroid disorders
  • Obesity management
  • Growth disorders

DR SUPRATIK BHATTACHARYYA
Consultant

  • Director, SKN Diabetes & Endocrine centre, Naihati (India)
  • Consultant, Endocrinology; AMRI Hospital Saltlake, APOLLO SUGAR, Kolkata; Bhagirati Neotia Hospital, Kolkata & Suraksha Diabetes (India)
  • 11+ years of dedicated practice in Diabetes, Obesity and Endocrinology, post specialisation (17 + years of Clinical Practice)

Work Experience:

  • Visiting Lecturer, Endocrinology & Diabetes, University of South Wales, UK (2018-2019)
  • Consultant, Endocrinology and Diabetes:
    • AMRI Saltlake since May 2015
    • Apollo Sugar Clinic since 2016

Organisational Positions :-

  • Founder President, AMOCE (Association of Metabolic and Obesity Physicians and Clinical Endocrinologists)
  • Part of RSSDI Defeat Diabetes Taskforce
  • Secretary, DRWA & Scientific Secretary DRWA National conference 2022
  • Scientific Secretary, ACP India chapter conference 2021
  • Organising Chairman, National Obesity Conclave 2022
  • Organising Chairman, National SGLT2i PLUS symposium 2021
  • Organising committee for ACP IM 2021, Diabetes India 2021, DiaVcon2020, DiaCon 2020
  • National Co-ordinator for International DiaVcon Conference 2020
  • Organising Secretary, International Incretin Summit 2020
  • Organising Secretary, National SGLT2i symposium 2020
     

Research Experience

Publications:- 30+ International publications as first/corresponding author, few are listed below

  1.  Kalra S, Bhattacharyya S, Bioequivalence study of two different dapagliflozin tablet formulations in healthy adult Indian volunteers. 2022 | Volume:  13 | Issue Number:  3 | Page: 235-241
  2.  Bhattacharyya S. et al, Semaglutide Oral in Indian T2DM Patients (SOLID) Study Baseline Demographics, AACE poster 2022 (to be published in Endocrine Practice)
  3.  Bhattacharyya S. et al, A Single Center Cross-sectional Study of Body Composition in Patients with Newly Diagnosed Type 2 Diabetes Mellitus, AACE poster 2022 (to be published in Endo Prac)
  4.  Bhattacharyya S. EFFICACY AND SAFETY OF LIRAGLUTIDE IN AN INDIAN ADOLESCENT POPULATION WITH T2DM AND OBESITY: A SINGLE CENTRE EXPERIENCE FROM EASTERN INDIA, ATTD poster 2022
  5.  Bhattacharyya S. Efficacy and Safety of Empagliflozin and Linagliptin Combination in Non-hospitalized COVID-19 Positive Patients with T2DM in Real World Setting: A Single Center Retrospective Study Endocrine Practice. 2021, ISSN: 1530-891X, Vol: 27, Issue: 6, Page: S57
  6.  Bhattacharyya S. Efficacy and Safety of Once-Daily Fixed-Ratio Coformulation of Degludec-Aspart plus Empa-Lina 25/5 FDC in Post-Discharge COVID-19 Pneumonitis T2DM Patients Treated with Dexamethasone during Inpatient Stay, Diabetes Jun 2021, 70 (Supplement 1) 723-P; 
  7.  Bhattacharyya S. Clinical Effectiveness of Dulaglutide Monotherapy in Obese Indian Adults with Prediabetes: First Report of A Real-World Retrospective Study in India. EndocrPract. 2019;25(Suppl 1):s104
  8.  Bhattacharyya S. Safety and Efficacy of Faster Acting Insulin Aspart in People with Type 2 Diabetes and Chronic Kidney Disease: A Real-World Study from India. EndocrPract. 2020;26(Suppl 2):s101-2
  9.  Bhattacharyya S. Real-World Clinical Effectiveness of Empagliflozin & Linagliptin Combination (Empa/Lina) in Indian T2D Subjects who are not willing to continue Insulin Therapy. EndocrPract. 2020;26(Suppl 2):s160
  10. 1 Bhattacharyya S. Clinical effectiveness of combination therapy with dulaglutide, SGLT2 inhibitor and metformin with or without insulin in Indian adults with type 2 diabetes: a real-world retrospective study. Clinical Diabetology 2020; Jul 27. DOI: 10.5603/DK.2020.0026 [Epub ahead of print]
  11.  Bhattacharyya S, Bhattacharyya S, Bhattacharyya K. Saroglitazar and its impact on Diabetic Dyslipidemia: A Real life Observational study from Eastern India. Indian Journal of Basic and Applied Medical Research. 2018; 7(2): 298-303.
  12.  Bhattacharyya S, Bhattacharyya S. Safety and Efficacy of Insulin Degludec/Liraglutide Fixed-ratio Combination in Oad Failure Type 2 Diabetes Patients in a Tertiary Care Centre in Eastern India. Int J Diab 2020;7-9
     Bhattacharyya S, Khalse M. Clinical Effectiveness of Empagliflozin and Linagliptin Combination in Overweight or Obese T2DM Patients: Indian Real World Experience. Int J Diab 2020;14-18
  13.  Bhattacharyya S, Bhattacharyya S, Bhattacharyya K. Evaluation of blood lipid parameters in type 2 diabetes mellitus subjects and its correlation with glycosylated hemoglobin: a prospective study from Eastern India. Indian Journal of Basic and Applied Medical Research. 2017; 6(2): 696-701.
  14.  Bhattacharyya S, Mondal S, Pradhan R, Bhattacharyya D. Comparison of efficacy, compliance and incidence of hypoglycemia between conventional basal bolus and Oral hypoglycemic (OHA) regimen with a basal plus oral hypoglycemic regimen. International journal of Pharmaceutical Biological and Chemical Sciences. 2015; 4(4):16-19.
  15.  Das AK, Mehndiratta C, Kalra S, Dhingra A, Tiwaskar M, Bhattacharyya S, et al. Medical nutrition therapy in diabetes management: A healthcare professional centric survey. Research & Reviews: Journal of Medical and Health Sciences. 2019;8 (Suppl Joint Event on Asia Pacific Conference on Diabetes & Oncology):s29
  16.  Bhattacharyya S. Abstract B-04181: Adaptation of IDF-DAR guidance in real world practice: incidence of hypoglycaemia in patients observing ramadan fast. In: Proceedings of IDF Congress 2019, 2019 Dec 3-6; Busan. 2019. Available from: https://doi.org/10.26226/morressier.5d9b6234ea541d6ca8494051
    Book Chapters:- 5 book chapters including:
    1. Bhattacharyya S. Chap 47. Aligning Therapeutic Options with Management Goals in Elderly Patients with Diabetes. In: Saboo B, editors. RSSDI Diabetes Update 2019. New Delhi, Jaypee publishers; 2019. P214-218
    2.  Bhattacharyya S. Chap 47. DCCT & UKPDS. In: Saboo B, editors. RSSDI Diabetes Update 2020. New Delhi, Jaypee publishers; 2020.

Awards & Achievements

  1.  ‘Inspiring Endocrinologist & Diabetologist of India Award 2022’ –Economic Times (Doctor’s Day Conclave’ New Delhi 2022)
  2.  ‘International Rising Star Award 2021’- International Diabetes Center, Park Nicollet
  3.  ‘Rising star Award 2021’ (Endocrinology &Diabetes)- Indian Academy of Diabetes
  4.  RSSDI 2020 award for ‘Best innovation in Diabetes Care during challenging times’
  5.  ‘Best Oral Paper presentation’ – ASIA Pacific Congress of Hypertension 2021
  6.  ‘ACP Governor’s Recognition Award 2021’, for exceptional contribution as Scientific Secretary ACP India Annual Conference 2022
  7.  Best National Diabetes Awareness Initiative Award 2016, by DIABETES INDIA at 7 th World Congress of Diabetes, Feb 2017
  8.  National Scholar & Rank holder in 10 th Board exam & Gold certificate holder in A-level exam (UK)
  9.  Distinction holder in Medical school & Post Graduation
     

Related Specialists
Dr Amal Kumar Sinha
Dr Amal Kumar S...
(Consultant)
Qualifications

MBBS(CAL), MRCP FRCP...

Visit Profile
Dr Shiladitya Nandi
Dr Shiladitya N...
(SENIOR CONSULTANT & DIRECTOR)
Qualifications

MBBS - 1996-2001. M...

Visit Profile
Dr Sujoy Ghosh
Dr Sujoy Ghosh
(SENIOR CONSULTANT & DIRECTOR)
Qualifications

MBBS, MD, DM(ENDOCRI...

Visit Profile
Dr Sagarika Mukherjee
Dr Sagarika Muk...
(Consultant)
Qualifications

MRCP (London), FRCP...

Visit Profile
Dr Monojit Ketan Mukhopadhyay
Dr Monojit Keta...
(SENIOR CONSULTANT & DIRECTOR)
Qualifications

MBBS,MD,FRCP

Visit Profile

Online Report